The role of oxidative stress in the pathogenesis of multiple sclerosis: The need for effective antioxidant therapy
By Y. Gilgun-Sherki, E. Melamed, D. Offen. Journal of Neurology, 2004
645 citations recorded by the source corpus.
Subfields: Complementary and alternative medicine, Molecular Biology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/51921438a808ca5adf21ee982b94a0fff2bcaeaa
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
Citations in the corpus
- Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. (2012, neutral): “Upper abdominal pain‡ 17 (5) 36 (10) 33 (10) 4 (1)”
- The Role of Selenium in Inflammation and Immunity: From Molecular Mechanisms to Therapeutic Opportunities (2012, background): “ROS have also been suggested to be involved in the pathogenesis of multiple sclerosis (86) and type-1 diabetes (40).”
- Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS) (2011, background): “…oxygen species (ROS) have been implicated in inflammatory diseases including rheumatoid arthritis (Filippin et al., 2008), multiple sclerosis (Gilgun-Sherki et al., 2004), thyroiditis (Burek and Rose, 2008), and type 1 diabetes (Chen et al., 2008).”